In the BRCA2 mutation-related cases with invasive counterparts (N = 16), 63% (10/16) of DCIS lesions were HIF-1α positive as compared to 38% (6/16) if invasive lesions (p = 0.016). The gene discussed is HIF1A; the disease is ductal breast carcinoma in situ.